Lithium Vanadium Phosphate (Li3V2(PO4)3)5g

3-(3,4-Dimethoxyphenyl)-1H-pyrazol-5-amine, 1g

n-Benzyl-4-methylaniline, 97%, 1g

ETHYL 4-CYCLOPROPYLTHIAZOLE-2-CARBOXYLATE, 95.0%, 1g

(4S,4'S)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

N-METHOXY-N-METHYLISOXAZOLE-3-CARBOXAMIDE, 95.0%, 100mg

6-Bromo-1,5-dimethylpyrimidine-2,4(1H,3H)-dione, 98%, 1g

(S)-2,6-Diaminohexanoic acid compound with (S)-2-aminosuccinic acid (1:1), 95.0%, 100g

Methyl 5-bromo-2-cyanobenzoate, 95.0%, 1g

2,4-Dihydroxybenzene-1,3,5-tricarbaldehyde, 97%, 10g

3-Bromo-2-methylbenzoic acid, 98.0%, 100g

2-Methyl-5,7-dihydrothieno[3,4-d]pyrimidine, 95.0%, 250mg

Colonna capillare per GC ROTI®Cap-5, 30 m, 0.32 mm, 5.00 µm, 1 Pezzo(i)